Trials / Withdrawn
WithdrawnNCT03109470
The Durability of Early RA Disease Control After Tocilizumab Withdrawal: A Canadian Experience
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Pope Research Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients who participated in the FUNCTION Study (Protocol WA19926) will be enrolled in this study. The investigators want to learn how long it takes Early Rheumatoid Arthritis patients who were treated with Tocilizumab to require treatment with another biologic medication.
Conditions
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2017-04-12
- Last updated
- 2017-04-13
Source: ClinicalTrials.gov record NCT03109470. Inclusion in this directory is not an endorsement.